S2Medical AB (OSTO:S2M) ROC (Joel Greenblatt) %: -5,991.21% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is S2Medical AB ROC (Joel Greenblatt) %?

S2Medical AB OSTO:S2M +4.00% ROC (Joel Greenblatt) % is -5,991.21% as of Dec. 2025. The stock has 3 warning signs investors should review. Among 837 Medical Devices & Instruments companies, S2Medical AB ranks worse than 97.37% on this metric.

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. S2Medical AB's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was -5,991.21%.

The historical rank and industry rank for S2Medical AB's ROC (Joel Greenblatt) % or its related term are showing as below:

OSTO:S2M' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -3167.03   Med: -564.87   Max: 817.6
Current: -2995.6

During the past 10 years, S2Medical AB's highest ROC (Joel Greenblatt) % was 817.60%. The lowest was -3167.03%. And the median was -564.87%.

OSTO:S2M's ROC (Joel Greenblatt) % is ranked worse than
97.37% of 837 companies
in the Medical Devices & Instruments industry
Industry Median: 4.35 vs OSTO:S2M: -2995.60

S2Medical AB's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was 0.00% per year.


S2Medical AB  (OSTO:S2M) ROC (Joel Greenblatt) % Explanation

The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.

Joel Greenblatt uses his definition of Return on Capital and Earnings Yield (Joel Greenblatt) % to rank companies.


S2Medical AB ROC (Joel Greenblatt) % Related Terms


S2Medical AB ROC (Joel Greenblatt) % Historical Data

* Premium members only.

The historical data trend for S2Medical AB's ROC (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

S2Medical AB ROC (Joel Greenblatt) % Chart

S2Medical AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROC (Joel Greenblatt) %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1,001.31 -1,890.03 -1,578.49 817.60 -3,167.03

S2Medical AB Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Dec25
ROC (Joel Greenblatt) % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1,808.86 -1,370.12 2,345.28 -955.40 -5,991.21

OSTO:S2M vs ISRG, BDX, MDLN: ROC (Joel Greenblatt) % Comparison

For the Medical Instruments & Supplies subindustry, S2Medical AB's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


S2Medical AB ROC (Joel Greenblatt) % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, S2Medical AB's ROC (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where S2Medical AB's ROC (Joel Greenblatt) % falls into.



S2Medical AB ROC (Joel Greenblatt) % Calculation

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:

ROC (Joel Greenblatt) %=EBIT/Average of (Net fixed Assets + Net Working Capital)

EBIT stands for Earnings Before Interest and Taxes.

Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.

GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.

Working Capital(Q: Dec. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(2.159 + 0.406 + 1.276) - (0.649 + 0 + 5.991)
=-2.799

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.693 + 0.393 + 1.105) - (0.91 + 0 + 6.117)
=-4.836

When net working capital is negative, 0 is used.

So ROC (Joel Greenblatt) % of S2Medical AB for the quarter that ended in Dec. 2025 can be restated as:

ROC (Joel Greenblatt) %(Q: Dec. 2025 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2024  Q: Dec. 2025
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-19.082/( ( (0.434 + max(-2.799, 0)) + (0.203 + max(-4.836, 0)) )/ 2 )
=-19.082/( ( 0.434 + 0.203 )/ 2 )
=-19.082/0.3185
=-5,991.21 %

Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROC (Joel Greenblatt) % of -5,991.21% mean?
S2Medical AB (OSTO:S2M) has a ROC (Joel Greenblatt) % of -5,991.21% as of Dec. 2025. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on S2Medical AB and its competitors. According to the industry distribution chart, S2Medical AB ranks #815 out of 837 companies in the Medical Devices & Instruments industry, placing it in the top 97.4%.
Is S2Medical AB's ROC (Joel Greenblatt) % too high?
S2Medical AB's current ROC (Joel Greenblatt) % is -5,991.21%. Based on the distribution chart, S2Medical AB ranks #815 out of 837 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers.
How does S2Medical AB's ROC (Joel Greenblatt) % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, S2Medical AB ranks #815 out of 837 companies for ROC (Joel Greenblatt) %. This places S2Medical AB in the lower half of its industry. The industry median ROC (Joel Greenblatt) % is 4.35. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Medical Devices & Instruments company?
The median ROC (Joel Greenblatt) % among Medical Devices & Instruments companies is 4.35, based on 837 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on S2Medical AB and its competitors. For the Medical Devices & Instruments industry, the median ROC (Joel Greenblatt) % is 4.35 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. S2Medical AB's current ROC (Joel Greenblatt) % is -5,991.21%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is S2Medical AB stock overvalued right now?
Based on GuruFocus' analysis, S2Medical AB (OSTO:S2M) is currently considered Possible Value Trap. The stock's GF Value™ is kr0.01, compared to a current price of kr0.01 — trading 48% below its estimated fair value. The current ROC (Joel Greenblatt) % is -5,991.21%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For S2Medical AB (OSTO:S2M), the current ROC (Joel Greenblatt) % is -5,991.21% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

S2Medical AB Business Description

Other Exchanges S21:Germany
Address Sunnorpsgatan 5, Linkoping, SWE, 582 73
S2Medical AB is a research-intensive MedTech company from Sweden. The company develops products within the entire wound healing process from debridement and granulation to re-epithelialization. products for the initial phase of a wound's healing process until the end, when the wound is completely healed. S2Medical also has in its portfolio the product NoSmell for odor removal which is procured in several different Swedish healthcare regions.